C-Amylin + G1-S Blend

C-Amylin + G1-S Blend contains two synthetic peptide sequences with distinct but complementary receptor targets studied together in non-human metabolic signaling and neuroendocrine axis research models. C-Amylin is a synthetic amylin analogue studied in relation to amylin receptor (AMY receptor complex) signaling, calcitonin receptor pathway activity, and pancreatic peptide hormone axis behavior in non-human models. G1-S is a synthetic GLP-1 receptor agonist analogue studied in relation to GLP-1 receptor (GLP-1R) binding, incretin pathway signaling, and downstream metabolic axis regulation in non-human research environments. Scientific literature examines amylin and GLP-1 receptor pathway compounds both independently and in combination within complementary metabolic signaling and energy homeostasis research frameworks.

Research applications commonly explored in the literature include:

Amylin receptor complex (AMY) signaling and calcitonin receptor pathway activity investigation in non-human models

GLP-1 receptor binding selectivity and incretin pathway signaling research in metabolic frameworks

Dual amylin and GLP-1 receptor pathway co-activation modeling in non-human research systems

Pancreatic peptide hormone axis signaling and downstream metabolic regulation pathway research

Comparative single versus dual receptor pathway activation studies in non-human metabolic signaling models

Neuroendocrine axis peptide interaction and complementary signaling cascade investigation in controlled laboratory settings

The lyophilized vial format preserves compound integrity across both peptide sequences within a single preparation, allowing researchers to evaluate reconstitution characteristics, blend stability, and handling parameters under controlled laboratory conditions. Each C-Amylin + G1-S Blend vial from KÖLD is prepared and filled in the United States under sterile laboratory conditions. All batches are verified by independent third-party laboratories for purity, volume accuracy, and molecular identity of both peptide components.

1. What are C-Amylin and G1-S individually studied for?
C-Amylin is a synthetic amylin analogue studied in non-human models in relation to AMY receptor complex signaling, calcitonin receptor pathway activity, and pancreatic peptide hormone axis behavior. G1-S is a synthetic GLP-1 receptor agonist analogue studied in relation to GLP-1R binding selectivity and incretin pathway signaling in metabolic research frameworks. Scientific literature examines amylin and GLP-1 receptor pathway compounds within overlapping metabolic axis and neuroendocrine signaling research models.

2. Why are C-Amylin and G1-S studied in combination?
Scientific literature examines amylin receptor and GLP-1 receptor pathway compounds together due to their complementary and non-overlapping receptor targets within metabolic signaling research — amylin receptor complex activity and GLP-1 receptor incretin signaling each engage distinct pathway nodes within neuroendocrine and pancreatic axis research. Multi-peptide study designs allow researchers to investigate whether concurrent dual-receptor pathway activation produces differentiated metabolic signaling outcomes compared to single-receptor models.

3. Why is this blend provided in a lyophilized vial format?
The lyophilized format preserves the integrity of both peptide sequences within a single preparation, supporting compound stability, extended storage, and controlled handling during research preparation. This format allows researchers to evaluate reconstitution behavior and blend stability under consistent laboratory conditions.

4. Is the C-Amylin + G1-S Blend approved for any use in humans or animals?
No. This product is not approved for human or veterinary use. All products sold by KÖLD are strictly for in vitro and non-human laboratory research purposes only.

5. How is purity and quality verified for a multi-compound blend?
Each C-Amylin + G1-S Blend vial undergoes independent third-party laboratory testing to confirm molecular identity, purity, and volume accuracy for both peptide components prior to release. Certificates of Analysis reflect testing results for each compound within the blend.

Before Reconstitution

Store sealed vial in a freezer at -20°C (–4°F)

Keep away from light and humidity

After Reconstitution

Store at 4°C (39°F)

Use within 14 days

Avoid repeated freeze-thaw cycles

This compound is supplied as a lyophilized powder.
Use KÖLD Solution (sterile, lab-grade solvent) if your protocol requires reconstitution.
Reconstitute only when ready to begin your study.
For research use only. Not for human or animal use.
Not intended to diagnose, treat, cure, or prevent any disease.